A clinical prediction tool to estimate the number of units of red blood cells needed in primary elective coronary artery bypass surgery. Transfusion. 2010;50:2343. 1083. Dial S, Delabays E, Albert M, et al. Hemodilution and surgical hemo- stasis contribute significantly to transfusion requirements in patients undergoing coronary artery bypass. J Thorac Cardiovasc Surg. 2005; 130:654 61. 1084. Khanna MP, Hebert PC, Fergusson DA. Review of the clinical practice literature on patient characteristics associated with perioperative allo- geneic red blood cell transfusion. Transfus Med Rev. 2003;17:110 9. 1085. Parr KG, Patel MA, Dekker R, et al. Multivariate predictors of blood product use in cardiac surgery. J Cardiothorac Vasc Anesth. 2003;17: 176 81. 1086. DeBois W, Liu J, Lee L, et al. Cardiopulmonary bypass in patients with pre-existing coagulopathy. J Extra Corpor Technol. 2005;37:15 22. 1087. Lee LY, DeBois W, Krieger KH, et al. The effects of platelet inhibitors on blood use in cardiac surgery. Perfusion. 2002;17:33 7. 1088. Berkowitz SD, Stinnett S, Cohen M, et al. Prospective comparison of hemorrhagic complications after treatment with enoxaparin versus unfractionated heparin for unstable angina pectoris or non-ST-segment elevation acute myocardial infarction. Am J Cardiol. 2001;88:1230 4. 1089. Ferraris VA, Ferraris SP, Joseph O, et al. Aspirin and postoperative bleeding after coronary artery bypass grafting. Ann Surg. 2002;235: 820 7. 1090. Johnson WC, Williford WO. benefits, morbidity, and mortality asso- ciated with long-term administration of oral anticoagulant therapy to patients with peripheral arterial bypass procedures: a prospective ran- domized study. J Vasc Surg. 2002;35:413 21. 1091. Fuller J, Copeland J. Does short-term preoperative aspirin in coronary bypass patients increase post-operative bleeding? Vasc Surg. 1985;19: 174 8. 1092. Karwande SV, Weksler BB, Gay WA Jr, et al. Effect of preoperative antiplatelet drugs on vascular prostacyclin synthesis. Ann Thorac Surg. 1987;43:318 22. 1093. 